GAYATHRI DASHARATHY: Open Payments
NPI 1801966338 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$246 in 11 payments from 6 companies in 2025. Trend: 2023 $339 · 2024 $271 · 2025 $246
Food & beverage: $246
| Company | Payments | Amount |
|---|---|---|
| Veloxis Pharmaceuticals, Inc. | 3 | $77 |
| Otsuka America Pharmaceutical, Inc. | 3 | $63 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $37 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $26 |
| Vanda Pharmaceuticals Inc. | 1 | $24 |
| Merck Sharp & Dohme LLC | 1 | $18 |
Products named: ENVARSUS, XIFAXAN, REXULTI, ABILIFY ASIMTUFII, LIVTENCITY, FANAPT, PREVYMIS.
Industry payments across OK — which companies pay providers there.
